Know Cancer

or
forgot password

AVIDA The Vidaza® (Azacitidine) Patient Registry


N/A
N/A
N/A
Open (Enrolling)
Both
Myelodysplastic Syndromes

Thank you

Trial Information

AVIDA The Vidaza® (Azacitidine) Patient Registry


Inclusion Criteria:



- Patient who is deemed appropriate for treatment with Vidaza® by his or her clinician,
but who has not already started receiving Vidaza® treatment.

- Patient who is able to read and speak English.

- Patient who is willing and able to provide informed consent.

- Patient who agrees to complete patient assessment questionnaires.

Exclusion Criteria:

- Patients who are currently being treated with Vidaza®.

- Patients who are concurrently participating in a clinical trial.

- Patients unwilling or unable to complete the baseline and follow-up questionnaires.

- Patients who are deemed inappropriate for treatment with Vidaza®.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

David L. Grinblatt, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

NorthShore University HealthSystem Research Institute

Authority:

United States: Institutional Review Board

Study ID:

AVIDA

NCT ID:

NCT00481273

Start Date:

October 2006

Completion Date:

June 2010

Related Keywords:

  • Myelodysplastic Syndromes
  • MDS
  • Myelodysplastic Syndromes
  • Preleukemia

Name

Location

AVIDA Registry HelpKansas City, Missouri  66210